Previous studies also found that IRF6 exhibited tumor suppressor activity in several cancer, while promoter hypermethylation of IRF6 was associated with poor prognosis in gastric cancer and squamous cell carcinoma [29–31]. This evidence concerns the gene IRF6 and cancer.